Proton Radiotherapy for Recurrent Tumors
Brief description of study
The purpose of this study is to determine if using proton radiotherapy to re-treat recurrent cancer is feasible.
Detailed description of study
While proton radiation therapy is approved for tumors by the US food and Drug Administration (FDA), it has not been widely studied for the re-treatment of recurrent tumors. This study plans to use a newer form of radiation therapy called proton radiation, and to determine if its use is safe and effective in people with different types of cancer. This study is observational, which means participants will not be asked to participate in any investigational treatment.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Cancer,Solid Tumors
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
31 Oct 2022.
Study ID: 811027